| Literature DB >> 30383820 |
Marianna Thordardottir1, Ebba K Lindqvist2, Sigrun H Lund3, Rene Costello4, Debra Burton4, Laufey Steingrimsdottir5, Neha Korde6, Sham Mailankody6, Gudny Eiriksdottir7, Lenore J Launer8, Vilmundur Gudnason1,7, Tamara B Harris8, Ola Landgren6, Johanna E Torfadottir3,9, Sigurdur Y Kristinsson1,2.
Abstract
The etiology of monoclonal gammopathy of undetermined significance (MGUS), the precursor state of multiple myeloma (MM), is mostly unknown and no studies have been conducted on the effect of diet on MGUS or progression from MGUS to MM. We aimed to explore the association between common foods and MGUS and progression to MM. Data from the population-based AGES Study (N = 5,764) were utilized. Food frequency questionnaire was used to assess dietary intake during adolescence, midlife, and late life. Serum protein electrophoresis and serum free light-chain assay was performed to identify MGUS (n = 300) and LC-MGUS cases (n = 275). We cross linked our data with the Icelandic Cancer Registry to find cases of MM in the study group. We found that intake of fruit at least three times per week during adolescence was associated with lower risk of MGUS when compared to lower fruit consumption (OR = 0.62, 95% CI 0.41-0.95). We additionally found that intake of fruit at least three times per week during the late life period was associated with decreased risk of progressing from MGUS to MM (HR = 0.34, 95% CI 0.13-0.89) when compared to lower intake. Adolescent intake of fruit may reduce risk of MGUS, whereas fruit intake after MGUS onset may reduce risk of progressing to MM. Our findings suggest that diet might alter the risk of developing MGUS and progression to MM.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30383820 PMCID: PMC6211667 DOI: 10.1371/journal.pone.0206047
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of study participants at AGES study entry.
| Without MGUS | MGUS | LC-MGUS | MM | LP | |
|---|---|---|---|---|---|
| n = 5,150 (90.0%) | n = 300 (5.2%) | n = 275 (4.8%) | n = 18 (3.1%) | n = 11 (5.1%) | |
| Gender, n. (%) | |||||
| Female | 3,046 (59.1) | 141 (47.0) | 119 (43.3) | 10 (55.6) | 13 (46.4) |
| Male | 2,104 (40.9) | 159 (53.0) | 156 (56.7) | 8 (44.4) | 15 (53.6) |
| Mean age, years (range) | 76.8 (66–98) | 78.3 (67–93) | 79.4 (66–97) | 77.8 (69–87) | 77.5 (68–87) |
| BMI, kg/m2 (mean) | 27.0 | 26.7 | 27.0 | 27.2 | 26.5 |
| BMI midlife, kg/m2 (mean) | 25.2 | 25.5 | 25.6 | 26.2 | 26.2 |
*Proportion of cases that progressed from MGUS or LC-MGUS.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS—Light chain monoclonal gammopathy of undetermined significance, MM—Multiple myeloma, LP—Other lymphoproliferative diseases.
The association between diet in adolescence and MGUS and LC-MGUS.
| Model 1 | Model 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No MGUS | MGUS | LC-MGUS | MGUS | LC-MGUS | MGUS | LC-MGUS | |||||
| n (%) | n (%) | n (%) | OR | 95%CI | OR | 95% CI | OR | 95%CI | OR | 95% CI | |
| ≤ 2 portions p/w | 2,335 (49.1) | 140 (52.2) | 99 (40.7) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| > 2 portions p/w | 2,424 (50.9) | 128 (47.8) | 144 (59.3) | 0.85 | 0.66–1.09 | 1.33 | 1.02–1.73 | 0.88 | 0.68–1.14 | 1.39 | 1.06–1.83 |
| less than weekly | 2,280 (47.6) | 119 (44.4) | 128 (52.7) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| weekly or more | 2,509 (52.4) | 149 (55.6) | 115 (47.3) | 1.13 | 0.88–1.45 | 0.82 | 0.63–1.06 | 1.14 | 0.89–1.48 | 0.87 | 0.66–1.14 |
| 3 times a month or less | 2,210 (46.4) | 128 (47.8) | 114 (46.9) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| once p/w or more | 2,555 (53.6) | 140 (52.2) | 129 (53.1) | 0.85 | 0.66–1.10 | 0.84 | 0.64–1.09 | 0.95 | 0.71–1.26 | 0.89 | 0.66–1.21 |
| 2 times p/w or less | 1,689 (35.3) | 103 (38.6) | 91 (37.6) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 3,093 (64.7) | 164 (61.4) | 151 (62.4) | 0.87 | 0.67–1.12 | 0.89 | 0.68–1.17 | 0.89 | 0.68–1.15 | 0.86 | 0.62–1.14 |
| 3 times a month or less | 3,111 (65.2) | 184 (68.7) | 157 (64.9) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Once a week or more | 1,663 (34.8) | 84 (31.3) | 85 (35.1) | 0.79 | 0.60–1.03 | 0.90 | 0.68–1.18 | 0.82 | 0.61–1.10 | 0.94 | 0.69–1.28 |
| less than daily | 1,074 (22.4) | 65 (24.3) | 63 (25.9) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| daily | 3,719 (77.6) | 203 (75.7) | 180 (74.1) | 0.87 | 0.65–1.17 | 0.79 | 0.59–1.07 | 0.91 | 0.67–1.24 | 0.85 | 0.62–1.17 |
| 2 times p/w or less | 4,077 (85.3) | 241 (89.9) | 217 (89.7) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 701 (14.7) | 27 (10.1) | 25 (10.3) | 0.71 | 0.47–1.06 | 0.75 | 0.49–1.15 | 0.62 | 0.41–0.95 | 0.81 | 0.52–1.26 |
| 2 times p/w or less | 3,517 (73.5) | 197 (73.8) | 197 (81.1) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 1,265 (26.5) | 70 (26.2) | 46 (18.9) | 1.06 | 0.80–1.41 | 0.71 | 0.51–0.99 | 1.17 | 0.87–1.57 | 0.78 | 0.55–1.10 |
| less than daily | 2,481 (52.0) | 141 (52.6) | 120 (49.4) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| daily | 2,289 (48.0) | 127 (47.4) | 123 (50.6) | 0.88 | 0.68–1.14 | 0.94 | 0.72–1.22 | 0.94 | 0.71–1.23 | 1.00 | 0.75–1.34 |
| less than weekly | 1,252 (26.1) | 74 (27.6) | 68 (28.0) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| weekly or more | 3,539 (73.9) | 194 (72.4) | 175 (72.0) | 0.84 | 0.63–1.11 | 0.78 | 0.58–1.04 | 0.86 | 0.65–1.18 | 0.85 | 0.61–1.18 |
| 2 times p/w or less | 2,119 (44.4) | 110 (41.4) | 108 (44.6) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 2,650 (55.7) | 156 (58.6) | 134 (55.4) | 1.02 | 0.79–1.31 | 0.84 | 0.64–1.09 | 1.09 | 0.83–1.44 | 0.93 | 0.70–1.24 |
| less than daily | 483 (10.1) | 35 (13.1) | 25 (10.3) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| daily | 4,300 (89.9) | 233 (86.9) | 217 (89.7) | 0.76 | 0.52–1.10 | 0.99 | 0.64–1.51 | 0.81 | 0.55–1.20 | 1.04 | 0.67–1.63 |
aAdjusted for age and sex.
bAdjusted for age, sex and the other food groups.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS—Light chain monoclonal gammopathy of undetermined significance, OR—Odds ratio, CI—confidence interval
The association between midlife diet and MGUS and LC-MGUS.
| Model 1 | Model 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No MGUS | MGUS | LC-MGUS | MGUS | LC-MGUS | MGUS | LC-MGUS | |||||
| n (%) | n (%) | n (%) | OR | 95%CI | OR | 95% CI | OR | 95%CI | OR | 95% CI | |
| ≤ 2 portions p/w | 565 (11.8) | 35 (13.1) | 33 (13.6) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| > 2 portions p/w | 4,204 (88.2) | 233 (86.9) | 209 (86.4) | 0.84 | 0.58–1.22 | 0.77 | 0.52–1.13 | 0.87 | 0.59–1.28 | 0.80 | 0.54–1.19 |
| less than weekly | 1,852 (38.7) | 97 (36.3) | 97 (39.9) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| weekly or more | 2,931 (61.3) | 170 (63.7) | 146 (60.1) | 1.09 | 0.84–1.41 | 0.94 | 0.72–1.23 | 1.10 | 0.84–1.44 | 0.95 | 0.72–1.25 |
| 3 times a month or less | 3,241 (67.8) | 187 (69.8) | 161 (66.3) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| once p/w or more | 1,541 (32.2) | 81 (30.2) | 82 (33.7) | 0.81 | 0.62–1.07 | 0.91 | 0.67–1.20 | 0.82 | 0.60–1.13 | 0.90 | 0.65–1.25 |
| 2 times p/w or less | 1,809 (37.8) | 106 (39.6) | 93 (38.3) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 2,977 (62.2) | 162 (60.4) | 150 (61.7) | 0.94 | 0.73–1.21 | 1.03 | 0.78–1.35 | 0.93 | 0.72–1.21 | 1.00 | 0.76–1.32 |
| 3 times a month or less | 3,530 (73.8) | 199 (74.3) | 170 (70.2) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Once a week or more | 1,252 (26.2) | 69 (25.7) | 72 (29.8) | 0.89 | 0.67–1.18 | 1.05 | 0.79–1.40 | 0.95 | 0.68–1.32 | 1.12 | 0.80–1.56 |
| less than daily | 1,957 (40.9) | 99 (37.1) | 90 (37.2) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| daily | 2,823 (59.1) | 168 (62.9) | 152 (62.8) | 1.11 | 0.86–1.43 | 1.08 | 0.82–1.41 | 1.17 | 0.89–1.53 | 1.15 | 0.87–1.53 |
| 2 times p/w or less | 3,271 (68.4) | 185 (69.0) | 181 (74.5) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 1,512 (31.6) | 83 (31.0) | 62 (25.5) | 1.10 | 0.84–1.44 | 0.88 | 0.65–1.19 | 1.19 | 0.87–1.62 | 0.84 | 0.60–1.18 |
| 2 times p/w or less | 3,081 (64.6) | 182 (68.2) | 162 (66.7) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 1,692 (35.4) | 85 (31.8) | 81 (33.3) | 0.92 | 0.70–1.20 | 1.02 | 0.77–1.34 | 0.84 | 0.62–1.14 | 1.11 | 0.81–1.52 |
| less than daily | 3,264 (68.1) | 185 (69.0) | 166 (68.3) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| daily | 1,526 (31.9) | 83 (31.0) | 77 (31.7) | 0.86 | 0.66–1.13 | 0.83 | 0.62-.1.10 | 0.91 | 0.68–1.22 | 0.84 | 0.62–1.15 |
| less than weekly | 2,322 (48.5) | 123 (45.9) | 112 (46.1) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| weekly or more | 2,466 (51.5) | 145 (54.1) | 131 (53.9) | 1.05 | 0.82–1.35 | 1.00 | 0.77–1.30 | 1.07 | 0.82–1.39 | 1.00 | 0.76–1.33 |
| 2 times p/w or less | 2,910 (60.9) | 147 (55.1) | 140 (57.9) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 3 times p/w or more | 1,869 (39.1) | 120 (44.9) | 102 (42.1) | 1.18 | 0.92–1.52 | 1.01 | 0.77–1.31 | 1.27 | 0.94–1.60 | 1.05 | 0.80–1.40 |
| less than daily | 742 (15.5) | 48 (17.9) | 40 (16.5) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| daily | 4,046 (84.5) | 220 (82.1) | 203 (83.5) | 0.80 | 0.58–1.11 | 0.86 | 0.60–1.22 | 0.82 | 0.58–1.16 | 0.88 | 0.61–1.28 |
| 4 times p/w or less | 1,489 (31.2) | 101 (38.1) | 87 (36.1) | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 5 times p/w or more | 3,291 (68.8) | 164 (61.9) | 154 (63.9) | 0.76 | 0.59–0.98 | 0.83 | 0.64–1.09 | 0.75 | 0.57–0.99 | 0.86 | 0.64–1.15 |
aAdjusted for age and sex.
bAdjusted for age, sex and the other food groups.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS—Light chain monoclonal gammopathy of undetermined significance, OR—Odds ratio, CI—confidence interval.
The association between late life diet and risk of progression from MGUS and LC-MGUS to multiple myeloma and other lymphoproliferative diseases.
| Total | Multiple | Multiple myeloma | Multiple | Multiple myeloma | |||
|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | HR | 95%CI | HR | 95% CI | |
| ≤ 2 portions p/w | 149 (29.2) | 7 (41.2) | 10 (35.7) | 1.00 | 1.00 | ||
| > 2 portions p/w | 361 (70.8) | 10 (58.8) | 18 (64.3) | 0.62 | 0.24–1.64 | 0.77 | 0.35–1.67 |
| less than weekly | 152 (29.9) | 6 (35.3) | 9 (32.1) | 1.00 | 1.00 | ||
| weekly or more | 357 (70.1) | 11 (64.7) | 19 (64.9) | 0.81 | 0.30–2.22 | 0.91 | 0.41–2.03 |
| less than once a month | 371 (72.7) | 13 (76.5) | 21 (75.0) | 1.00 | 1.00 | ||
| once a month or more | 139 (27.3) | 4 (23.5) | 7 (25.0) | 0.95 | 0.30–2.95 | 1.00 | 0.42–2.39 |
| 2 times p/w or less | 186 (36.4) | 5 (29.4) | 6 (21.4) | 1.00 | 1.00 | ||
| 3 times p/w or more | 325 (63.6) | 12 (70.6) | 22 (78.6) | 1.47 | 0.51–4.21 | 2.18 | 0.88–5.41 |
| less than once a month | 341 (66.7) | 14 (82.4) | 20 (71.4) | 1.00 | 1.00 | ||
| once a month or more | 170 (33.3) | 3 (17.6) | 8 (28.6) | 0.47 | 0.13–1.68 | 0.84 | 0.36–1.96 |
| less than daily | 223 (43.7) | 8 (47.1) | 10 (35.7) | 1.00 | 1.00 | ||
| daily | 287 (56.3) | 9 (52.9) | 18 (64.3) | 0.96 | 0.37–2.50 | 1.56 | 0.72–3.39 |
| 2 times p/w or less | 151 (29.5) | 9 (52.9) | 13 (46.4) | 1.00 | 1.00 | ||
| 3 times p/w or more | 360 (70.5) | 8 (47.1) | 15 (53.6) | 0.34 | 0.13–0.89 | 0.45 | 0.21–0.96 |
| 2 times p/w or less | 270 (52.9) | 11 (64.7) | 16 (57.1) | 1.00 | 1.00 | ||
| 3 times p/w or more | 240 (47.1) | 6 (35.3) | 12 (42.9) | 0.54 | 0.20–1.49 | 0.78 | 0.36–1.67 |
| 2 times p/w or less | 225 (44.4) | 10 (58.8) | 15 (53.6) | 1.00 | 1.00 | ||
| 3 times p/w or more | 282 (55.6) | 7 (41.2) | 13 (46.4) | 0.57 | 0.22–1.52 | 0.70 | 0.33–1.48 |
| never | 111 (21.8) | 3 (17.6) | 6 (21.4) | 1.00 | 1.00 | ||
| ever | 398 (78.2) | 14 (82.4) | 22 (78.6) | 1.40 | 0.40–4.88 | 1.07 | 0.43–2.64 |
| 2 times p/w or less | 265 (51.9) | 9 (52.9) | 17 (60.7) | 1.00 | 1.00 | ||
| 3 times p/w or more | 246 (48.1) | 8 (47.1) | 11 (39.3) | 0.96 | 0.36–2.51 | 0.69 | 0.32–1.50 |
| less than daily | 220 (43.1) | 7 (41.2) | 12 (42.9) | 1.00 | 1.00 | ||
| daily | 290 (56.9) | 10 (58.8) | 16 (57.1) | 1.12 | 0.42–2.96 | 1.04 | 0.49–2.20 |
| 4 times p/w or less | 130 (25.5) | 4 (23.5) | 4 (14.3) | 1.00 | 1.00 | ||
| 5 times p/w or more | 380 (74.5) | 13 (76.5) | 24 (85.7) | 1.02 | 0.33–3.15 | 1.93 | 0.66–5.56 |
*Models adjusted for age and sex.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS–Light chain monoclonal gammopathy of undetermined significance, LP–lymphoproliferative, OR—Odds ratio, CI—confidence interval.